期刊文献+

系统性硬化症心脏损害的临床特点及血管内皮素-1的影响研究 被引量:2

The Impact of the Clinical Features of Systemic Sclerosis,Heart Damage and Vascular Endothelin-1
下载PDF
导出
摘要 目的探讨系统性硬化症(SSc)心脏损害的临床特征及血管内皮素-1的影响。方法共101例SSc患者进行甲襞微循环检查及血清血管内皮素-1测定。对45例有心脏损害的SSc临床进行回顾性分析。结果 SSc心脏损害累及瓣膜、心肌、心包、传导系统。SSc合并心脏损害甲襞微循环管襻形态积分、血流状态积分、襻周积分、总积分与SSc无心脏损害组比较明显升高,差异有统计学意义(P<0.05)。并发心脏损害的SSc患者ET-1水平高于无心脏损害者,差异有统计学意义(P<0.05)。结论 SSc伴心脏损害者心电图、心脏彩色多普勒超声检查可提高检出率及监测疗效,甲襞微循环检查及血清血管内皮素-1测定可能有助于早期判断SSc有无心脏损害。 Objective To evaluate the Clinical features with systemic sclerosis (SSc) heart damage and vascular en- dothelin - 1. Methods In 101 eases SSc patients nailfold miemcireulation examination and serum vascular endothelin - 1 deter- mination. Conducted a retrospective analysis of 45 cases of heart damage SSe clinical. Results SSc heart damage valve, myo- cardium, pericardium, conduction system involvement. SSc merged heart damage nailfold mieroeirculation pipe loop morphology integral, integral blood flow state loop weeks integral, the total score and the SSe heart damage group was significantly higher, the difference was statistically significant (P 〈0. 05). Concurrent cardiac damage SSc ET- 1 levels in patients with the higher heart damage, the difference was statistically significant (P 〈 0. 05 ). Conclusion SSc associated with cardiac damage ECG, cardiac Color Doppler ultrasound can improve the detection rate and monitoring the efficacy, the nailfold microcireulation exami- nation and serum vascular endothelin - 1 was measured to help determine whether heart damage.
出处 《临床合理用药杂志》 2013年第6期1-2,共2页 Chinese Journal of Clinical Rational Drug Use
基金 桂林市科学研究与技术开发计划基金项目(2012012-1-9) 广西卫生厅科研课题基金资助(Z2012405)
关键词 硬皮病 系统性 血管内皮素-1 Scleroderma, systemic Vascular endothelin - 1
  • 相关文献

参考文献13

  • 1Fernandes F, Ramires FJ, Arteaga E, et al. Cardiac remodeling inpatients with systemic sclerosis with no signs or symptoms of heart fail-ure :an endomyocardial biopsy study [ J]. Card Fail, 2003,9 : 311-317.
  • 2田牛 单毅.实用微循环学[M].北京:军事科学出版社,1989.177-189.
  • 3Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demograph-ic, clinical, and scwlogic features and survival in 1012 Italian patients[J]. Medicine (Baltimore), 2002, 81: 139 -153.
  • 4Tan FK. Systemic sclerosis : the susceptible host ( genetics and envi-ronment )[J] . Rheum Dis Clin North Am, 2003,29 (2) : 211 —237.
  • 5Maricq HR, Harper FE, Khan MM, et al. Microvascular abnormali-ties as possible predictors of disease subsets in Raynaud phenomenon andearly connective tissue disease [ J]. Clin Exp Rheumatol, 1983, 1(3): 195 -205.
  • 6Denton CP,Abraham DJ. Transforming growth factor - beta and con-nective tissue growth factor : key cytokines in scleroderma pathogenesis[J]. Curr Opin Rheumatol, 2001, 13 (6): 505 -511.
  • 7Ramsey S, Orrell D, Bolouri H. Dizzy: stochastic simulation of large-scale genetic regulatory networks ( supplementary material) [ J ].Bioinform Comput Biol, 2005,3 (2): 437 —454.
  • 8Kabasakal Yf Elvins DM, Ring EF, et al. Quantitative nailfold capil-laroscopy findings in a population with connective tissue disease and innormal healthy controls [ J] . Ann Rheum Dis,1996, 55 (81): 507-512.
  • 9Knock GA,Terenghi C, Bunker CB,et al. Characterization of endo-thelin - binding sites in human skin and their regulation in primaryRaynaud's phenomenon and systemic sclerosi [J]. Invest Dermatol,1993,101 (1) ; 73 -78.
  • 10Kahaieh MB. Endothelin, an endothelial - dependent vasoconstrictorin scleroderma. Enhanced production and profibrotic action [J]. Ar-thritis Rheum, 1991, 34 (8): 978 -983.

二级参考文献5

共引文献17

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部